After nearly quadrupling over the past month, it's time to get out of Moderna (MRNA) stock, a Citi analyst said Wednesday as he downgraded shares to a sell rating. Citi's Geoff Meacham's downgrade ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Grail (GRAL) stock catapulted Monday on positive briefing documents ahead of a key Food and Drug Administration meeting slated for Wednesday. The meeting will determine whether experts view Grail's ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Popular crypto analyst and influencer, Kyle Doops, screens altcoins by relative strength rather than by how far they have fallen. BeInCrypto ran that test across the 20 largest non-stablecoin assets.